Legionnaires’ disease (LD) is a form of atypical pneumonia caused by Gram-negative bacteria of the genus Legionella [Reference Murdoch and Chambers1]. LD is reported less commonly in Asian countries, especially in China. In the past 10 years, cases of infection by Legionella have been reported in China only sporadically or in small outbreaks [Reference Li2–Reference Zhang5]. In China, most patients use antibiotics prior to hospital admission, and it is difficult to obtain strains from respiratory specimens. In a previous report, we described four cases of Legionella pneumophila infections associated with liver cirrhosis; of these cases three were identified by real-time polymerase chain reaction (real-time PCR) [Reference Qin4].
Isolation of Legionella is considered the ‘gold standard’ for the diagnosis, but culture-confirmed diagnosis of Legionella infections is often hampered by early antibiotic treatment and demanding culture requirements. The urinary antigen (UAG) test is commonly used to diagnose LD; however, the present UAG test reagents could detect only L. pneumophila serogroup 1 (Lp1) with non-Lp1 LD being missed. Furthermore, because of its high cost, the UAG test is unlikely to be widely used in economically underdeveloped regions. The benefit of performing PCR methods on respiratory samples is now clearly established, especially for diagnosing other species and serogroups than Lp1 [Reference Maurin6–Reference Murdoch8]. In a study conducted by Murdoch et al. in New Zealand, a >fourfold increase in the number of detected cases of LD by real-time PCR compared to culture was obtained [Reference Murdoch8]. In the present study, we undertook a retrospective survey to detect Legionella in patients with pneumonia or other lower respiratory tract infections (LRTIs). Nested sequence-based typing (SBT) was used for analyses of the population structure of real-time PCR-positive specimens.
A real-time PCR-based survey was performed in two hospitals in Shanghai, China. Real-time PCR focusing on the 5S rRNA gene, which has a specificity of 100% and a sensitivity of 10 copies of genomic DNA, as described previously, was undertaken [Reference Qin4, Reference Mahbubani9, Reference Qin10]. Real-time reactions were conducted in a quantitative PCR instrument (Stratagene, USA) and conditions were as follows: an initial denaturing step of 95°C for 2 min, followed by 40 cycles of 95°C for 10 s and 60°C for 20 s. During the study period, patients were sampled who had symptoms of pneumonia or other LTRIs (cough, expectoration, moist rales on lung, and one of the following: fever, neutrophilic infiltration, or changes by chest radiography) and where Streptococcus pneumoniae and Haemophilus influenza had been excluded. A total of 265 bronchoalveolar lavage fluid (BALF) specimens were collected from hospital A between January 2012 and December 2013, and 359 sputum specimens were collected from hospital B throughout 2012. All specimens were analysed by culture method using buffered charcoal-yeast extract agar with α-ketoglutarate (BCYE; Oxoid, UK) and no Legionella isolates were obtained from any specimen. These specimens were collected in our laboratory and tested for Legionella by real-time PCR. The overall positive rate among 624 cases was 11·4%. A total of 71 specimens were positive for Legionella according to real-time PCR: 41 (15·5%) BALF specimens from hospital A and 30 (8·4%) sputum specimens from hospital B (Table 1). Real-time PCR focusing on the dotA gene (which is restricted in L. pneumophila) was performed to test the 71 specimens [Reference Yáñez11]. Seventy were identified as L. pneumophila as a result of real-time PCR amplification of the dotA gene.
BAL, Bronchoalveolar lavage.
The 71 cases of Legionella infection were aged 23–76 (median 58·4) years and 48 (67·6%) were male. All 71 cases were community acquired as the symptoms were observed before hospital admission. Upon hospital admission, six (8·5%) of these cases were diagnosed with pneumonia, 43 (60·6%) had lung shadows, 17 (23·9%) had fever with cough, three (4·2%) had pleural effusion, and two (2·8%) had a lung abscess. All 71 patients had changes consistent with pneumonia according to chest radiography after hospital admission. In hospital A, positive rates were slightly higher during the first and fourth quarters than in the second and third quarters, especially in 2012. In hospital B, the number of positive cases and positive rates were higher in the fourth quarter than in the other quarters (Fig. 1). There is trend of seasonal variation of positive rates and case numbers, in particular the autumn peak is consistent with the pattern found in other regions [Reference Bentham and Broadbent12]; however, a survey with a larger sample size should be performed to obtain a more accurate conclusion.
All 71 real-time PCR-positive specimens were tested by nested SBT using a protocol described previously [Reference Ginevra13]. A full 7-allele profile was obtained for 44/71 (62·0%) specimens, a further 13/71 (18·3%) specimens gave 5- or 6-allele profiles [usually sufficient to identify the strain as belonging to one or two sequence types (STs)], 4/71 (5·6%) gave 3- or 4-allele profiles (usually sufficient to differentiate one profile from another), and 9/71 (12·7%) gave 1- or 2-allele profiles (sufficient to distinguish strains). Overall, 70/71 (98·6%) gave at least one allele. Of 41 BALF specimens, 80·5% (n = 33) gave a full profile. Only 36·7% (11/30) sputum specimens gave a full profile, and 40·0% (12/30) of sputum specimens gave 5- or 6-allele profiles (Supplementary Table S1).
Of 44 specimens in which the full 7-allele profile was obtained, 28 STs were identified with a Simpson diversity index of 0·9567, suggesting high genetic polymorphism [Reference Hunter and Gaston14]. A minimum spanning tree based on 28 STs was structured using BioNumerics v. 7·1 software (www.applied-maths.com) (Fig. 2). Of the 28 STs, 12 could be assigned a ST number and the other 16 STs were identified for the first time using the EWGLI SBT database (www.ewgli.org). ST1, ST154 and ST377 were also detected in our previous environmental surveys in China [Reference Qin15, Reference Qin16]. Of these three STs, ST1 was the predominant ST in strains isolated from all types of water systems [Reference Qin16]; the ST377 strain was detected in hot springs [Reference Qin15]; ST154 was detected in cooling towers and hot springs [Reference Qin16]. This data is consistent with the widely recognized role that cooling towers and hot springs play in the causation of LD. ST1 is also the predominant ST of clinical and environmental isolates worldwide [Reference Qin16–Reference Borchardt18]. Seven STs (ST7, ST10, ST304, ST952, ST1030, ST1113, ST1735) in this study were single-locus variants (SLVs) of ST1. Two specimens that gave 6-allele profiles were in accordance with that of ST1. ST377 (6-10-15-28-9-14-1) was the second most predominant ST in this study, and was contained in five specimens.
The current system used to monitor Legionella in China is focused on environmental water samples rather than clinical samples [Reference Qin19, Reference Guo20], and a systematic survey has not been reported. The major finding from this study is that the burden of LD in China is much greater than recognized previously. However, data regarding the UAG test is lacking and the prevalence of LD in this study is probably underestimated as several studies have shown that the UAG test can be more sensitive than PCR in respiratory samples for diagnosing LD [Reference Chen21]. Combining real-time PCR and the UAG test may have better application for diagnosing LD. A systemic survey synchronous with UAGs, PCR and culture should be conducted in China in the future. Furthermore, using nested SBT allows extending the results of population structure to uncultivable clinical Legionella strains.
SUPPLEMENTARY MATERIAL
For supplementary material accompanying this paper visit http://dx.doi.org/10.1017/S0950268815003301.
ACKNOWLEDGEMENTS
This study was supported by the National Natural Scientific Foundation (No. 81 201 251) from the Ministry of Science and Technology of the People's Republic of China, and the Priority Project on Infectious Disease Control and Prevention (Nos. 2013ZX10004610 and 2012ZX10004215-003) from the Ministry of Health and the Ministry of Science and Technology of the People's Republic of China.
DECLARATION OF INTEREST
None.